IGRA TB LIOFeron®, unique test, excludes TB by M. bovis

LIOFeron® IGRA, novel and specific MTB test Zoonotic TB causes major economic losses world-wide ( https://www.who.int/tb/areas-of-work/zoonotic-tb/en/). Active tuberculosis (TB) in human is caused by Mycobacterium tuberculosis (MTB) and M. bovis,…

mehr IGRA TB LIOFeron®, unique test, excludes TB by M. bovis

CANKADO’s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies

The tool is a drug tailored extension of CANKADO’s e-Health solution Cologne, Germany, 17.12.2020 – CANKADO’s Companion-APP solution provides an environment that helps to build a drug-tailored digital connected care…

mehr CANKADO’s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies

medically effective alpha – linolenic acid (ALA) product. To be awarded worldwide under license.

The product is strong anti-inflammatory, lowers TNF-alpha by 60%, activates cells. Approval available. Marketing possible immediately. Due to the current pandemic, we have decided to license our ALA product to…

mehr medically effective alpha – linolenic acid (ALA) product. To be awarded worldwide under license.

Treat anal fistula with „FiLaC“ laser therapy – avoid incontinence, preserve sphincter

biolitec’s innovative FiLaC laser treatment for anal fistulas enables significant protection of the sphincter muscle and surrounding tissue – flexible laser probe is also suitable for complicated fistulas Jena, 29th…

mehr Treat anal fistula with „FiLaC“ laser therapy – avoid incontinence, preserve sphincter

CANKADO e-Health support for epilepsy patients under ketogenic diet therapies in Argentina

‚My Keto Life‘ is an e-Health tool developed on the CANKADO platform by a team composed of healthcare Professionals, B-LIFE: an Argentinean nutrition company and CANKADO Latin America Cologne, Germany,…

mehr CANKADO e-Health support for epilepsy patients under ketogenic diet therapies in Argentina

Corona: PDT drug Foscan with active ingredient Temoporfin potentially suitable against COVID-19

biolitec’s photosensitizer Foscan has unimagined potential against SARS-CoV-2 – Virtual screening shows Temoporfin among other substances as a promising inhibitor of Corona envelope protein Jena, 12th October 2020 – Research…

mehr Corona: PDT drug Foscan with active ingredient Temoporfin potentially suitable against COVID-19